[
    {
        "question_id": "1_B_469",
        "new_question_id": "8911",
        "question_type": "0",
        "category": "4",
        "concept_id_link": "3604",
        "notes_id_link": "1_503",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Stop smoking",
            "Start statin therapy",
            "Eat more omega-3 fatty acids",
            "Start sulfonylurea therapy",
            "Weight loss",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 52-year-old woman is diagnosed with non-alcoholic steatohepatitis following a liver biopsy. What is the single most important step to help prevent the progression of her disease?",
            "",
            ""
        ],
        "answers": [
            "5",
            "",
            ""
        ],
        "notes": [
            "The correct answer is <b>Weight loss</b>. Non-alcoholic steatohepatitis (NASH) is a progressive form of non-alcoholic fatty liver disease (NAFLD), which can lead to cirrhosis, hepatocellular carcinoma and liver failure. The mainstay of treatment for NASH is lifestyle modification, with weight loss being the most effective intervention. According to UK guidelines, reducing body weight by 7-10% can lead to significant histological improvement in NASH. <br /><br /><b>Stop smoking</b> is an incorrect choice as while it's generally good advice for overall health and certain liver diseases such as primary biliary cirrhosis and alcoholic liver disease, there's no direct evidence that smoking cessation alone will prevent the progression of NASH.<br /><br /><b>Start statin therapy</b> would not be the single most important step in this case. While statins can lower cholesterol levels and reduce cardiovascular risk, they have not been proven to reverse or halt the progression of NASH specifically.<br /><br />The option <b>Eat more omega-3 fatty acids</b> may provide some benefit for NAFLD patients due to their anti-inflammatory properties but again, they are not considered a primary treatment strategy according to UK guidelines. More research is needed in this area.<br /><br />Finally, <b>Start sulfonylurea therapy</b> is also incorrect. Sulfonylureas are a class of medications used in type 2 diabetes management but they do not directly address the pathophysiology of NASH. In fact, these medications could potentially exacerbate weight gain which would be counterproductive in managing NASH.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 52-year-old woman is diagnosed with non-alcoholic steatohepatitis following a liver biopsy. What is the single most important step to help prevent the progression of her disease?",
        "correct_answer": "5",
        "question_notes": "The correct answer is <b>Weight loss</b>. Non-alcoholic steatohepatitis (NASH) is a progressive form of non-alcoholic fatty liver disease (NAFLD), which can lead to cirrhosis, hepatocellular carcinoma and liver failure. The mainstay of treatment for NASH is lifestyle modification, with weight loss being the most effective intervention. According to UK guidelines, reducing body weight by 7-10% can lead to significant histological improvement in NASH. <br /><br /><b>Stop smoking</b> is an incorrect choice as while it's generally good advice for overall health and certain liver diseases such as primary biliary cirrhosis and alcoholic liver disease, there's no direct evidence that smoking cessation alone will prevent the progression of NASH.<br /><br /><b>Start statin therapy</b> would not be the single most important step in this case. While statins can lower cholesterol levels and reduce cardiovascular risk, they have not been proven to reverse or halt the progression of NASH specifically.<br /><br />The option <b>Eat more omega-3 fatty acids</b> may provide some benefit for NAFLD patients due to their anti-inflammatory properties but again, they are not considered a primary treatment strategy according to UK guidelines. More research is needed in this area.<br /><br />Finally, <b>Start sulfonylurea therapy</b> is also incorrect. Sulfonylureas are a class of medications used in type 2 diabetes management but they do not directly address the pathophysiology of NASH. In fact, these medications could potentially exacerbate weight gain which would be counterproductive in managing NASH.",
        "answer_order": "5",
        "answer": "5",
        "title": "Non-alcoholic fatty liver disease",
        "body": "Non-alcoholic fatty liver disease (NAFLD) is now the most common cause of liver disease in the developed world. It is largely caused by obesity and describes a spectrum of disease ranging from:<br /><ul><li>steatosis - fat in the liver</li><li>steatohepatitis - fat with inflammation, non-alcoholic steatohepatitis (NASH), see below</li><li>progressive disease may cause fibrosis and liver cirrhosis</li></ul><br />NAFLD is thought to represent the hepatic manifestation of the metabolic syndrome and hence <span class=\"concept\" data-cid=\"721\">insulin resistance</span> is thought to be the key mechanism leading to steatosis.<br /><br />Non-alcoholic steatohepatitis (NASH) is a term used to describe liver changes similar to those seen in alcoholic hepatitis in the absence of a history of alcohol abuse. It is relatively common and thought to affect around 3-4% of the general population. The progression of disease in patients with NASH may be responsible for a proportion of patients previously labelled as cryptogenic cirrhosis.<br /><br />Associated factors<br /><ul><li><span class=\"concept\" data-cid=\"11101\">obesity</span></li><li><span class=\"concept\" data-cid=\"721\">type 2 diabetes mellitus</span></li><li>hyperlipidaemia</li><li>jejunoileal bypass</li><li><span class=\"concept\" data-cid=\"4462\">sudden weight loss/starvation</span></li></ul><br />Features<br /><ul><li>usually asymptomatic</li><li>hepatomegaly</li><li><span class=\"concept\" data-cid=\"3981\">ALT is typically greater than AST</span></li><li>increased echogenicity on ultrasound</li></ul><br />NICE produced guidelines on the investigation and management of NAFLD in 2016. Key points:<br /><ul><li>there is no evidence to support screening for NAFLD in adults, even in at risk groups (e.g. type 2 diabetes)</li><li>the guidelines are therefore based on the management of the <i>incidental</i> finding of NAFLD - typically asymptomatic fatty changes on liver ultrasound</li><li>in these patients, NICE recommends the use of the <span class=\"concept\" data-cid=\"8322\">enhanced liver fibrosis (ELF)</span> blood test to check for advanced fibrosis</li><li>the ELF blood test is a combination of hyaluronic acid + procollagen III + tissue inhibitor of metalloproteinase 1. An algorithm based on these values results in an ELF blood test score, similar to triple testing for Down's syndrome</li></ul><br />An excellent review by Byrne et Al<sup>1</sup> in 2018 reviewed the diagnosis and monitoring of NAFLD. It made the following suggestions if the ELF blood test was not available:<br /><ul><li>non-invasive tests may be used to assess the severity of fibrosis</li><li>these include the FIB4 score or NALFD fibrosis score</li><li>these scores may be used in combination with a FibroScan (liver stiffness measurement assessed with transient elastography)</li><li>this combination has been shown to have excellent accuracy in predicting fibrosis</li></ul><br />Patients who are likely to have advanced fibrosis should be referred to a liver specialist. They will then likely have a liver biopsy to stage the disease more accurately.<br /><br />Management<br /><ul><li>the mainstay of treatment is lifestyle changes (particularly <span class=\"concept\" data-cid=\"3604\">weight loss</span>) and monitoring</li><li>there is ongoing research into the role of gastric banding and insulin-sensitising drugs (e.g. metformin, <span class=\"concept\" data-cid=\"1538\">pioglitazone</span>)</li></ul><br /><b>References</b><br />1. BMJ 2018;362:k2734",
        "notes_hash": "d4be84bc5e5eebcf4269bd7fa71cb0f6",
        "knowledge_graph_node_id_link": 1195,
        "concept": "Weight loss is the best first line management for NAFLD",
        "concept_percentile": "55",
        "concept_colour": "rgb(229,255,0)",
        "number_attempts": "5577",
        "up_votes": "17",
        "down_votes": "6",
        "column_array": [
            0,
            "536",
            "444",
            "98",
            "51",
            "4448",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>NICE</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1206\" data-linkid=\"1206\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_1206\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">14</span><button type=\"button\" style=\"\" id=\"link_dislike_1206\" data-linkid=\"1206\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_1206\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">14</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.nice.org.uk/guidance/ng49/chapter/Recommendations\">2016 Non-alcoholic fatty liver disease (NAFLD): assessment and management</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/lGP9hNk64tg\" data-description=\"Understanding Non-Alcoholic Fatty Liver Disease\" data-upvotes=\"2\" data-downvotes=\"0\" data-media=\"1500\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/lGP9hNk64tg/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/lGP9hNk64tg\" data-description=\"Understanding Non-Alcoholic Fatty Liver Disease\" data-upvotes=\"2\" data-downvotes=\"0\" data-media=\"1500\">Understanding Non-Alcoholic Fatty Liver Disease</a></td></tr><tr><td><span ><small>Zero To Finals - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2643\" data-mediaid=\"2643\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2643\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">2</span><button type=\"button\" style=\"\" id=\"media_dislike_2643\" data-mediaid=\"2643\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2643\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://upload.wikimedia.org/wikipedia/commons/0/05/Non-alcoholic_fatty_liver_disease.webm\" data-description=\"Non-alcoholic fatty liver disease (NAFLD) - causes, symptoms, diagnosis, treatment, pathology\" data-upvotes=\"4\" data-downvotes=\"4\" data-media=\"22\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/css/images/osmosis.png\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://upload.wikimedia.org/wikipedia/commons/0/05/Non-alcoholic_fatty_liver_disease.webm\" data-description=\"Non-alcoholic fatty liver disease (NAFLD) - causes, symptoms, diagnosis, treatment, pathology\" data-upvotes=\"4\" data-downvotes=\"4\" data-media=\"22\">Non-alcoholic fatty liver disease (NAFLD) - causes, symptoms, diagnosis, treatment, pathology</a></td></tr><tr><td><span ><small>Osmosis - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_45\" data-mediaid=\"45\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_45\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">4</span><button type=\"button\" style=\"\" id=\"media_dislike_45\" data-mediaid=\"45\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_45\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">4</span></td></tr></table>",
        "comment_count": 2,
        "concepts_for_notes": {
            "721": {
                "concept_text": "T2DM with abnormal LFTs - ? non-alcoholic fatty liver disease",
                "concept_percentile": "72"
            },
            "3604": {
                "concept_text": "Weight loss is the best first line management for NAFLD",
                "concept_percentile": "55"
            },
            "8322": {
                "concept_text": "In patients with non-alcoholic fatty liver disease, enhanced liver fibrosis (ELF) testing is recommended to aid diagnosis of liver fibrosis",
                "concept_percentile": "74"
            },
            "11101": {
                "concept_text": "Obesity with abnormal LFTs - ? non-alcoholic fatty liver disease",
                "concept_percentile": "81"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "1_B_658",
        "new_question_id": "10864",
        "question_type": "0",
        "category": "1",
        "concept_id_link": "8258",
        "notes_id_link": "1_914",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Posterior myocardial infarction",
            "Anterolateral myocardial infarction",
            "Incorrectly placed ECG leads",
            "Acute pericarditis",
            "Inferior myocardial infarction",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 62-year-old man with a history of diabetes mellitus presents with a heavy feeling in his chest for the past 2 hours. An ECG is taken:<br /><br /><CENTER><table><tr><td align = 'left' colspan='2'><img class='ajaximage' src = 'https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/img016.jpg' /></td></tr><tr><td valign='top' align='left'></td><td align='right'></td></tr></table></CENTER><br />What is the most likely diagnosis?",
            "",
            ""
        ],
        "answers": [
            "5",
            "",
            ""
        ],
        "notes": [
            "",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 62-year-old man with a history of diabetes mellitus presents with a heavy feeling in his chest for the past 2 hours. An ECG is taken:<br /><br /><CENTER><table><tr><td align = 'left' colspan='2'><img class='ajaximage' src = 'https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/img016.jpg' /></td></tr><tr><td valign='top' align='left'></td><td align='right'></td></tr></table></CENTER><br />What is the most likely diagnosis?",
        "correct_answer": "5",
        "question_notes": "",
        "answer_order": "5",
        "answer": "5",
        "title": "ECG: coronary territories",
        "body": "The table below shows the correlation between ECG changes and coronary territories:<br /><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid1\" ><thead><tr><th></th><th><b>ECG changes</b></th><th><b>Coronary artery</b></th></tr></thead><tbody><tr><td><b>Anteroseptal</b></td><td><span class=\"concept\" data-cid=\"8257\">V1-V4</span></td><td>Left anterior descending</td></tr><tr><td><b>Inferior</b></td><td><span class=\"concept\" data-cid=\"8258\">II, III, aVF</span></td><td><span class=\"concept\" data-cid=\"915\">Right coronary</span></td></tr><tr><td><b>Anterolateral</b></td><td>V1-6, I, aVL</td><td>Proximal left anterior descending</td></tr><tr><td><b>Lateral</b></td><td><span class=\"concept\" data-cid=\"8259\">I, aVL +/- V5-6</span></td><td><span class=\"concept\" data-cid=\"4142\">Left circumflex</span></td></tr><tr><td><b>Posterior</b></td><td><span class=\"concept\" data-cid=\"4141\">Changes in V1-3</span><br /><br /><span class=\"concept\" data-cid=\"10019\">Reciprocal changes of STEMI</span> are typically seen:<br /><ul><li>horizontal ST depression</li><li>tall, broad R waves</li><li>upright T waves</li><li>dominant R wave in V2</li></ul><br />Posterior infarction is confirmed by ST elevation and Q waves in <span class=\"concept\" data-cid=\"11554\">posterior leads (V7-9)</span></td><td>Usually left circumflex, also right coronary</td></tr></tbody></table></div><br />It should be remembered that a <span class=\"concept\" data-cid=\"9647\">new left bundle branch block (LBBB)</span> may point towards a diagnosis of acute coronary syndrome.<br /><br /><CENTER><table><tr><td align = 'left' colspan='2'><a data-fancybox class='fancybox' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd519b.png'><img class='ajaximage' src='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd519.png'/></a></td></tr><tr><td valign='top' align='left'></td><td align='right'><a data-fancybox class='fancybox lbmagglasslink' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd519b.png'><img src='https://d32xxyeh8kfs8k.cloudfront.net/css/images/mag_glass.png'/></a></td></tr></table></CENTER><div class='imagetext'>Diagram showing the correlation between ECG changes and coronary territories in acute coronary syndrome<br /></div>",
        "notes_hash": "d9dc01438aaffe4cb31bc2261e5e181e",
        "knowledge_graph_node_id_link": 0,
        "concept": "Ischaemic changes in leads II, III, aVF - right coronary",
        "concept_percentile": "68",
        "concept_colour": "rgb(163,255,0)",
        "number_attempts": "4126",
        "up_votes": "5",
        "down_votes": "2",
        "column_array": [
            0,
            "225",
            "285",
            "24",
            "165",
            "3427",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>University of Massachusetts Medical School</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_659\" data-linkid=\"659\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_659\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">19</span><button type=\"button\" style=\"\" id=\"link_dislike_659\" data-linkid=\"659\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_659\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">36</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://escholarship.umassmed.edu/cgi/viewcontent.cgi?referer=&httpsredir=1&article=1019&context=oapubs\">Classic circumflex infarction ECG</a></td></tr></table><br><br><table style='width:100%'><tr><td>Postgraduate Medical Journal</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1017\" data-linkid=\"1017\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_1017\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">31</span><button type=\"button\" style=\"\" id=\"link_dislike_1017\" data-linkid=\"1017\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_1017\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">48</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://pmj.bmj.com/content/79/935/490.full\">ECG correlation with coronary anatomy</a></td></tr></table>",
        "media": "",
        "comment_count": 1,
        "concepts_for_notes": {
            "915": {
                "concept_text": "Inferior MI - right coronary artery lesion",
                "concept_percentile": "41"
            },
            "8257": {
                "concept_text": "Ischaemic changes in leads V1-V4 - left anterior descending",
                "concept_percentile": "50"
            },
            "8258": {
                "concept_text": "Ischaemic changes in leads II, III, aVF - right coronary",
                "concept_percentile": "68"
            },
            "8259": {
                "concept_text": "Ischaemic changes in leads I, aVL +/- V5-6 - left circumflex",
                "concept_percentile": "40"
            },
            "11554": {
                "concept_text": "Posterior infarction is confirmed by ST elevation and Q waves in posterior leads (V7-9) ",
                "concept_percentile": "38"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "1_E_5",
        "new_question_id": "4623",
        "question_type": "1",
        "category": "2",
        "concept_id_link": "0",
        "notes_id_link": "1_1785",
        "theme": "Neck lumps",
        "instruction": "For each one of the following scenarios select the most likely diagnosis",
        "options": [
            "",
            "Lymphoma",
            "Tuberculosis",
            "Reactive lymph nodes",
            "Cystic hygroma",
            "Branchial cyst",
            "Goitre",
            "Carotid aneurysm",
            "Pharyngeal pouch",
            "Thyroglossal cyst",
            "Cervical rib"
        ],
        "num_of_options": 10,
        "questions": [
            "A 75-year-old man presents with dysphagia and halitosis. On the left side of the neck is a small, fluctuant swelling which gurgles when palpated.",
            "L 54-jplc-zwo hzxly acpdpyed htes l ypnv dhpwwtyr. Dsp td djdepxtnlwwj hpww lalce qczx dzxp cpnpye hptrse wzdd. Zy pilxtyletzy dsp td yzepo ez slgp l xtowtyp, yzy-epyopc ypnv dhpwwtyr hstns xzgpd fahlcod hspy dsp dhlwwzhd.",
            "L yphmzcy mlmj td yzepo ez slgp l wlcrp dhpwwtyr zy esp wpqe-dtop zq esp ypnv. Zy pilxtyletzy l dzqe, qwfneflye lyo strswj eclydtwwfxtylmwp wfxa td yzepo ufde mpyples esp dvty."
        ],
        "answers": [
            "8",
            "6",
            "4"
        ],
        "notes": [
            "",
            "Patients with a goitre are often euthyroid or have minor symptoms. A thyroglossal cyst would be unusual at this age - they typically present in patients < 20 years old.",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 75-year-old man presents with dysphagia and halitosis. On the left side of the neck is a small, fluctuant swelling which gurgles when palpated.",
        "correct_answer": "8",
        "question_notes": "",
        "answer_order": "8",
        "answer": "8",
        "title": "Neck lumps",
        "body": "The table below gives characteristic exam question features for conditions causing neck lumps:<br /><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid1\" ><thead><tr><th><b>Condition</b></th><th><b>Notes</b></th></tr></thead><tbody><tr><td><b><span class=\"concept\" data-cid=\"7621\">Reactive lymphadenopathy</span></b></td><td>By far the most common cause of neck swellings. There may be a history of local infection or a generalised viral illness</td></tr><tr><td><b><span class=\"concept\" data-cid=\"7620\">Lymphoma</span></b></td><td>Rubbery, painless lymphadenopathy<br />The phenomenon of pain whilst drinking alcohol is very uncommon<br />There may be associated night sweats and splenomegaly</td></tr><tr><td><b>Thyroid swelling </b></td><td>May be hypo-, eu- or hyperthyroid symptomatically<br />Moves upwards on swallowing</td></tr><tr><td><b>Thyroglossal cyst</b></td><td>More common in patients < 20 years old<br />Usually midline, between the isthmus of the thyroid and the hyoid bone<br />Moves upwards with protrusion of the tongue<br />May be painful if infected</td></tr><tr><td><b><span class=\"concept\" data-cid=\"7623\">Pharyngeal pouch</span></b></td><td>More common in older men<br />Represents a posteromedial herniation between thyropharyngeus and cricopharyngeus muscles<br />Usually not seen but if large then a midline lump in the neck that gurgles on palpation<br />Typical symptoms are dysphagia, regurgitation, aspiration and chronic cough</td></tr><tr><td><b><span class=\"concept\" data-cid=\"7624\">Cystic hygroma</span></b></td><td>A congenital lymphatic lesion (lymphangioma) typically found in the neck, classically on the left side<br />Most are evident at birth, around 90% present before 2 years of age</td></tr><tr><td><b><span class=\"concept\" data-cid=\"7625\">Branchial cyst</span></b></td><td>An oval, mobile cystic mass that develops between the sternocleidomastoid muscle and the pharynx<br />Develop due to failure of obliteration of the second branchial cleft in embryonic development<br />Usually present in early adulthood</td></tr><tr><td><b><span class=\"concept\" data-cid=\"7626\">Cervical rib</span></b></td><td>More common in adult females<br />Around 10% develop thoracic outlet syndrome</td></tr><tr><td><b>Carotid aneurysm</b></td><td>Pulsatile lateral neck mass which doesn't move on swallowing</td></tr></tbody></table></div>",
        "notes_hash": "a02fb4dcdd212168d78593be31d90207",
        "knowledge_graph_node_id_link": 0,
        "concept": "",
        "concept_percentile": 0,
        "concept_colour": "",
        "number_attempts": "7694",
        "up_votes": "69",
        "down_votes": "61",
        "column_array": [
            0,
            "6865",
            "3561",
            "4715",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://upload.wikimedia.org/wikipedia/commons/f/fa/Thyroglossal_Duct_Cyst.webm\" data-description=\"Thyroglossal duct cyst\" data-upvotes=\"6\" data-downvotes=\"3\" data-media=\"388\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/css/images/osmosis.png\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://upload.wikimedia.org/wikipedia/commons/f/fa/Thyroglossal_Duct_Cyst.webm\" data-description=\"Thyroglossal duct cyst\" data-upvotes=\"6\" data-downvotes=\"3\" data-media=\"388\">Thyroglossal duct cyst</a></td></tr><tr><td><span ><small>Osmosis - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_667\" data-mediaid=\"667\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_667\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">6</span><button type=\"button\" style=\"\" id=\"media_dislike_667\" data-mediaid=\"667\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_667\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">3</span></td></tr></table>",
        "comment_count": 5,
        "concepts_for_notes": {
            "7620": {
                "concept_text": "A 30-year-old presents with a slowly enlarging lump in the submandibular area. It is non-tender and firm on examination. Splenomegaly is also noted - lymphoma",
                "concept_percentile": "32"
            },
            "7621": {
                "concept_text": "A 20-year-old man presents with tender, swollen 2cm mass in the right submandibular region. His temperature is 38.2degC and he is noted to have poor dental hygiene - reactive lymphadenopathy",
                "concept_percentile": "23"
            },
            "7623": {
                "concept_text": "A 75-year-old man presents with dysphagia, regurgitation and chronic cough. He is noted to have halitosis but otherwise examination is normal - pharyngeal pouch",
                "concept_percentile": "4"
            },
            "7624": {
                "concept_text": "A 1-year-old is noted to have a swelling on the left side of the neck. The mass is soft, non-tender and transilluminates - cystic hygroma",
                "concept_percentile": "33"
            },
            "7625": {
                "concept_text": "A 20-year-old presents with a painless swelling on the lateral aspect of the neck. On examination it is smooth, non-tender and fluctuant - branchial cyst",
                "concept_percentile": "29"
            },
            "7626": {
                "concept_text": "A 35-year-old woman is noted to have a firm swelling at the bottom of her neck. She has been suffering from weakness and numbness of her arm on the same side - cervical rib",
                "concept_percentile": "23"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "1_B_709",
        "new_question_id": "11200",
        "question_type": "0",
        "category": "2",
        "concept_id_link": "0",
        "notes_id_link": "1_974",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Right optic neuritis",
            "Left sided Horner's syndrome",
            "Craniopharyngioma",
            "Left optic neuritis",
            "Right Holmes-Adie pupil",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 34-year-old woman presents complaining of headaches. Examination of her pupils using a light shone alternately in each eye reveals that when the light is shone in the right eye both pupils constrict but when the light source immediately moves to the left eye both eyes appear to dilate.<br /><br />What is the most likely diagnosis?",
            "",
            ""
        ],
        "answers": [
            "4",
            "",
            ""
        ],
        "notes": [
            "This is the 'swinging light test' and reveals a relative afferent pupillary defect. As there is a defect in the afferent nerve on the left side the pupils constrict less than normal, giving the impression of dilation. <br /><br />Given her age, multiple sclerosis causing optic neuritis is the likely underlying diagnosis. Optic neuritis typically causes a dull ache in the region of the eye which is aggravated by movement",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 34-year-old woman presents complaining of headaches. Examination of her pupils using a light shone alternately in each eye reveals that when the light is shone in the right eye both pupils constrict but when the light source immediately moves to the left eye both eyes appear to dilate.<br /><br />What is the most likely diagnosis?",
        "correct_answer": "4",
        "question_notes": "This is the 'swinging light test' and reveals a relative afferent pupillary defect. As there is a defect in the afferent nerve on the left side the pupils constrict less than normal, giving the impression of dilation. <br /><br />Given her age, multiple sclerosis causing optic neuritis is the likely underlying diagnosis. Optic neuritis typically causes a dull ache in the region of the eye which is aggravated by movement",
        "answer_order": "4",
        "answer": "4",
        "title": "Relative afferent pupillary defect",
        "body": "Also known as the Marcus-Gunn pupil, a relative afferent pupillary defect is found by the 'swinging light test'. It is caused by a lesion anterior to the optic chiasm i.e. optic nerve or retina<br /><br />Finding<br /><ul><li><span class=\"concept\" data-cid=\"9549\">the affected and normal eye appears to dilate when light is shone on the affected</span></li></ul><br /><span class=\"concept\" data-cid=\"9548\">Causes</span><br /><ul><li>retina: detachment</li><li>optic nerve: optic neuritis e.g. multiple sclerosis</li></ul><br />Pathway of pupillary light reflex<br /><ul><li>afferent: retina &rarr; optic nerve &rarr; lateral geniculate body &rarr; midbrain</li><li>efferent: Edinger-Westphal nucleus (midbrain) &rarr; oculomotor nerve</li></ul>",
        "notes_hash": "27ffcff9271b539a27851f282d1ddaca",
        "knowledge_graph_node_id_link": 10525,
        "concept": "",
        "concept_percentile": 0,
        "concept_colour": "",
        "number_attempts": "3796",
        "up_votes": "4",
        "down_votes": "5",
        "column_array": [
            0,
            "223",
            "284",
            "197",
            "2185",
            "907",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>almostadoctor</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_321\" data-linkid=\"321\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_321\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">8</span><button type=\"button\" style=\"\" id=\"link_dislike_321\" data-linkid=\"321\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_321\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">5</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"http://almostadoctor.co.uk/content/systems/neurology-psychiatry/neurology/pupillary-defects\">Relative afferent pupillary defect tutorial</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/WrNYqNH3b3A\" data-description=\"Relative Afferent Pupillary Defect\" data-upvotes=\"10\" data-downvotes=\"1\" data-media=\"221\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/WrNYqNH3b3A/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/WrNYqNH3b3A\" data-description=\"Relative Afferent Pupillary Defect\" data-upvotes=\"10\" data-downvotes=\"1\" data-media=\"221\">Relative Afferent Pupillary Defect</a></td></tr><tr><td><span ><small>U-M Kellogg Eye Center - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_365\" data-mediaid=\"365\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_365\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">10</span><button type=\"button\" style=\"\" id=\"media_dislike_365\" data-mediaid=\"365\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_365\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">1</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/HSYo7LhfV3A\" data-description=\"How to examine RAPD\" data-upvotes=\"5\" data-downvotes=\"2\" data-media=\"347\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/HSYo7LhfV3A/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/HSYo7LhfV3A\" data-description=\"How to examine RAPD\" data-upvotes=\"5\" data-downvotes=\"2\" data-media=\"347\">How to examine RAPD</a></td></tr><tr><td><span ><small>Individual - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_589\" data-mediaid=\"589\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_589\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">5</span><button type=\"button\" style=\"\" id=\"media_dislike_589\" data-mediaid=\"589\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_589\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">2</span></td></tr></table>",
        "comment_count": 0,
        "concepts_for_notes": {
            "9548": {
                "concept_text": "Relative afferent pupillary defect indicates an optic nerve lesion or severe retinal disease",
                "concept_percentile": "85"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "20495_B_357",
        "new_question_id": "36280",
        "question_type": "0",
        "category": "11",
        "concept_id_link": "11596",
        "notes_id_link": "1_1717",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Combined hormone replacement therapy for 5 years",
            "Combined hormone replacement therapy until the age of 51",
            "No management is required",
            "Oestrogen-only hormone replacement therapy until the age of 51",
            "Progestogen-only pill until the age of 51",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 33-year-old woman presents to the GP as she has not had a period for 6 months. She has also noticed that she is sweating more at night and has had started to have the occasional hot flush, although she thinks this may just be due to the weather. She does not want children and has only come today to check there is no sinister cause for her lack of periods. She has no past medical history and no family history. <br /><br />Blood tests are as follows:<br /><br /><div class=\"table-responsive\"><table class = \"tb\" ><tbody><tr><td>TSH</td><td>2 mU/L</td><td>(0.5 - 5.5)</td></tr><tr><td>T4</td><td>10 pmol/L</td><td>(9 - 18)</td></tr><tr><td>Prolactin</td><td>15 \u00b5g/L</td><td>(<25)</td></tr><tr><td>FSH</td><td>75 iu/L</td><td>(<40)</td></tr><tr><td>Oestradiol</td><td>45 pmol/L</td><td>(>100)</td></tr></tbody></table></div><br />Bloods repeated 6 weeks later show no change.<br /><br />What is the most appropriate management?",
            "",
            ""
        ],
        "answers": [
            "2",
            "0",
            "0"
        ],
        "notes": [
            "Amenorrhea, climacteric symptoms (hot flushes and night sweats), lost oestradiol and raised gonadotrophins are all consistent with ovarian failure. As this patient is under 40, this is premature ovarian failure. The mainstay of treatment is hormone replacement therapy (which can also be given as the combined oral contraceptive pill) which is given until the age of natural menopause (around 51 years) to prevent osteoporosis, as well as to protect against symptoms of oestrogen deficiency and possible cardiovascular complications. As this patient has a uterus, she must not have unopposed oestrogen (due to the risk of endometrial cancer), so combined replacement should be given. Of the above options, the most appropriate answer is <b>combined hormone replacement therapy until the age of 51</b>.<br /><br /><b>Combined hormone replacement therapy for 5 years</b> is incorrect; although it is the correct treatment, it is needed until the age of natural menopause (i.e. longer than 5 years) to protect against osteoporosis. <br /><br /><b>No management is required</b> is incorrect. Hormone replacement therapy should be offered to all women with premature ovarian failure, not only to treat symptoms of low oestrogen but also to protect bone mineral density.<br /><br />This patient has a uterus. She, therefore, must not receive <b>oestrogen-only hormone replacement therapy</b>. Unopposed oestrogen will lead the uterine lining to proliferate, increasing the risk of endometrial cancer. <br /><br />The <b>progestogen-only pill</b> alone is inadequate treatment. Oestrogen is needed to treat symptoms of low oestrogen (such as hot flushes) and to promote bone mineral density. Progesterone is added to oppose oestrogen and reduce the risk of endometrial cancer.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 33-year-old woman presents to the GP as she has not had a period for 6 months. She has also noticed that she is sweating more at night and has had started to have the occasional hot flush, although she thinks this may just be due to the weather. She does not want children and has only come today to check there is no sinister cause for her lack of periods. She has no past medical history and no family history. <br /><br />Blood tests are as follows:<br /><br /><div class=\"table-responsive\"><table class = \"tb\" ><tbody><tr><td>TSH</td><td>2 mU/L</td><td>(0.5 - 5.5)</td></tr><tr><td>T4</td><td>10 pmol/L</td><td>(9 - 18)</td></tr><tr><td>Prolactin</td><td>15 \u00b5g/L</td><td>(<25)</td></tr><tr><td>FSH</td><td>75 iu/L</td><td>(<40)</td></tr><tr><td>Oestradiol</td><td>45 pmol/L</td><td>(>100)</td></tr></tbody></table></div><br />Bloods repeated 6 weeks later show no change.<br /><br />What is the most appropriate management?",
        "correct_answer": "2",
        "question_notes": "Amenorrhea, climacteric symptoms (hot flushes and night sweats), lost oestradiol and raised gonadotrophins are all consistent with ovarian failure. As this patient is under 40, this is premature ovarian failure. The mainstay of treatment is hormone replacement therapy (which can also be given as the combined oral contraceptive pill) which is given until the age of natural menopause (around 51 years) to prevent osteoporosis, as well as to protect against symptoms of oestrogen deficiency and possible cardiovascular complications. As this patient has a uterus, she must not have unopposed oestrogen (due to the risk of endometrial cancer), so combined replacement should be given. Of the above options, the most appropriate answer is <b>combined hormone replacement therapy until the age of 51</b>.<br /><br /><b>Combined hormone replacement therapy for 5 years</b> is incorrect; although it is the correct treatment, it is needed until the age of natural menopause (i.e. longer than 5 years) to protect against osteoporosis. <br /><br /><b>No management is required</b> is incorrect. Hormone replacement therapy should be offered to all women with premature ovarian failure, not only to treat symptoms of low oestrogen but also to protect bone mineral density.<br /><br />This patient has a uterus. She, therefore, must not receive <b>oestrogen-only hormone replacement therapy</b>. Unopposed oestrogen will lead the uterine lining to proliferate, increasing the risk of endometrial cancer. <br /><br />The <b>progestogen-only pill</b> alone is inadequate treatment. Oestrogen is needed to treat symptoms of low oestrogen (such as hot flushes) and to promote bone mineral density. Progesterone is added to oppose oestrogen and reduce the risk of endometrial cancer.",
        "answer_order": "2",
        "answer": "2",
        "title": "Premature ovarian insufficiency",
        "body": "Premature ovarian insufficiency is defined as the onset of menopausal symptoms and elevated gonadotrophin levels before the age of 40 years. It occurs in around 1 in 100 women.<br /><br />Causes of premature menopause include:<br /><ul><li>idiopathic<ul><li>the most common cause</li><li>there may be a family history</li></ul></li><li>bilateral oophorectomy<ul><li>having a hysterectomy with preservation of the ovaries has also been shown to advance the age of menopause</li></ul></li><li>radiotherapy</li><li>chemotherapy</li><li>infection: e.g. mumps</li><li>autoimmune disorders</li><li>resistant ovary syndrome: due to FSH receptor abnormalities</li></ul><br />Features are similar to those of the normal climacteric but the actual presenting problem may differ<br /><ul><li>climacteric symptoms: hot flushes, night sweats</li><li>infertility</li><li>secondary amenorrhoea</li><li>raised FSH, LH levels<ul><li>e.g. FSH > 30 IU/L</li><li><span class=\"concept\" data-cid=\"11597\">elevated FSH levels should be demonstrated on 2 blood samples taken 4-6 weeks apart</span></li></ul></li><li>low oestradiol<ul><li>e.g. < 100 pmol/l</li></ul></li></ul><br /><span class=\"concept\" data-cid=\"11596\">Management</span><br /><ul><li> hormone replacement therapy (HRT) or a combined oral contraceptive pill should be offered to women until the age of the average menopause (51 years)<ul><li>it should be noted that HRT does not provide contraception, in case spontaneous ovarian activity resumes</li></ul></li></ul>",
        "notes_hash": "b8cd92e2c638f0279cf8f3eb53a6e46c",
        "knowledge_graph_node_id_link": 1260,
        "concept": "Premature ovarian insufficiency: hormone replacement therapy (HRT) or a combined oral contraceptive pill should be offered to women until the age of 51 years",
        "concept_percentile": "91",
        "concept_colour": "rgb(45,255,0)",
        "number_attempts": "4394",
        "up_votes": "26",
        "down_votes": "16",
        "column_array": [
            0,
            "485",
            "3324",
            "250",
            "256",
            "79",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>NICE</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1415\" data-linkid=\"1415\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_1415\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">6</span><button type=\"button\" style=\"\" id=\"link_dislike_1415\" data-linkid=\"1415\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_1415\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">2</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.nice.org.uk/guidance/ng23/ifp/chapter/Premature-menopause-premature-ovarian-insufficiency\">Diagnosing premature menopause</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/-qRBHqCTOjE\" data-description=\"Understanding Early Menopause: Premature Ovarian Insufficiency\" data-upvotes=\"9\" data-downvotes=\"2\" data-media=\"1443\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/-qRBHqCTOjE/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/-qRBHqCTOjE\" data-description=\"Understanding Early Menopause: Premature Ovarian Insufficiency\" data-upvotes=\"9\" data-downvotes=\"2\" data-media=\"1443\">Understanding Early Menopause: Premature Ovarian Insufficiency</a></td></tr><tr><td><span ><small>Zero To Finals - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2548\" data-mediaid=\"2548\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2548\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">9</span><button type=\"button\" style=\"\" id=\"media_dislike_2548\" data-mediaid=\"2548\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2548\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">2</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/rxZBn88iUlM\" data-description=\"Premature ovarian failure\" data-upvotes=\"2\" data-downvotes=\"2\" data-media=\"384\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/rxZBn88iUlM/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/rxZBn88iUlM\" data-description=\"Premature ovarian failure\" data-upvotes=\"2\" data-downvotes=\"2\" data-media=\"384\">Premature ovarian failure</a></td></tr><tr><td><span ><small>Osmosis - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2722\" data-mediaid=\"2722\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2722\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">2</span><button type=\"button\" style=\"\" id=\"media_dislike_2722\" data-mediaid=\"2722\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2722\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">2</span></td></tr></table>",
        "comment_count": 3,
        "concepts_for_notes": {
            "11596": {
                "concept_text": "Premature ovarian insufficiency: hormone replacement therapy (HRT) or a combined oral contraceptive pill should be offered to women until the age of 51 years",
                "concept_percentile": "91"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "1_B_2234",
        "new_question_id": "8151",
        "question_type": "0",
        "category": "5",
        "concept_id_link": "0",
        "notes_id_link": "1_360",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Impossible to calculate",
            "50%",
            "25%",
            "No increased risk",
            "100%",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 60 year-old man with haemophilia A has just become a grandfather. He wants to know what the chances are of his daughter's son having haemophilia. His daughter's partner is well with no past medical history.<br /><br />What is the probability that his daughter's son has haemophilia A?",
            "",
            ""
        ],
        "answers": [
            "2",
            "0",
            "0"
        ],
        "notes": [
            "Haemophilia A is an X-linked recessive disease. This means that all female offspring of affected men will be carriers. There is then a 50% chance of these females passing the gene on. If the female's children are male, they will therefore have a 50% chance of having the condition.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 60 year-old man with haemophilia A has just become a grandfather. He wants to know what the chances are of his daughter's son having haemophilia. His daughter's partner is well with no past medical history.<br /><br />What is the probability that his daughter's son has haemophilia A?",
        "correct_answer": "2",
        "question_notes": "Haemophilia A is an X-linked recessive disease. This means that all female offspring of affected men will be carriers. There is then a 50% chance of these females passing the gene on. If the female's children are male, they will therefore have a 50% chance of having the condition.",
        "answer_order": "2",
        "answer": "2",
        "title": "X-linked recessive",
        "body": "In X-linked recessive inheritance only males are affected. An exception to this seen in examinations are patients with Turner's syndrome, who are affected due to only having one X chromosome. X-linked recessive disorders are transmitted by heterozygote females (carriers) and male-to-male transmission is not seen. Affected males can only have unaffected sons and carrier daughters.<br /><br />Each male child of a heterozygous female carrier has a 50% chance of being affected whilst each female child of a heterozygous female carrier has a 50% chance of being a carrier.<br /><br />The possibility of an affected father having children with a heterozygous female carrier is generally speaking extremely rare. However, in certain Afro-Caribbean communities G6PD deficiency is relatively common and homozygous females with clinical manifestations of the enzyme defect are seen.",
        "notes_hash": "23e72410ea6db2225caef8bdc2ef6608",
        "knowledge_graph_node_id_link": 0,
        "concept": "",
        "concept_percentile": 0,
        "concept_colour": "",
        "number_attempts": "4716",
        "up_votes": "88",
        "down_votes": "112",
        "column_array": [
            0,
            "359",
            "1816",
            "1079",
            "1336",
            "126",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "",
        "media": "",
        "comment_count": 11,
        "concepts_for_notes": [],
        "optimisation_reason": ""
    },
    {
        "question_id": "1_B_9404",
        "new_question_id": "960",
        "question_type": "0",
        "category": "10",
        "concept_id_link": "0",
        "notes_id_link": "1_1008",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Urgency + insomnia",
            "Dizziness + postural hypotension",
            "Urinary retention + nausea",
            "Urgency + erectile dysfunction",
            "Erectile dysfunction + reduced libido",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 69-year-old man is started on tamsulosin for benign prostatic hyperplasia. Which one of the following best describes the side-effects he may experience?",
            "",
            ""
        ],
        "answers": [
            "2",
            "",
            ""
        ],
        "notes": [
            "The correct answer is <b>Dizziness + postural hypotension</b>. Tamsulosin, an alpha-1 adrenergic receptor antagonist, primarily acts to relax the smooth muscle in the prostate and bladder neck. This leads to improved urine flow and reduced symptoms of benign prostatic hyperplasia (BPH). However, it can also cause systemic vasodilation as a side effect, leading to dizziness and postural hypotension. The British National Formulary (BNF) lists these as common side effects of tamsulosin.<br /><br />The option <b>Urgency + insomnia</b> is incorrect. While urinary urgency can be a symptom of BPH itself, it's not typically a side effect of tamsulosin treatment. Insomnia is also not listed as a common side effect in the BNF.<br /><br /><b>Urinary retention + nausea</b> is another incorrect answer. Tamsulosin is used to alleviate urinary retention caused by BPH, so it wouldn't cause this problem as a side effect. Nausea isn't commonly associated with tamsulosin either.<br /><br />The choice <b>Urgency + erectile dysfunction</b> is also wrong. As previously mentioned, tamsulosin doesn't typically cause urinary urgency. Although some patients might experience erectile dysfunction while taking tamsulosin, this isn't one of its most common side effects according to the BNF.<br /><br />Finally, <b>Erectile dysfunction + reduced libido</b> isn't the best answer either. These aren't among the most frequently observed adverse reactions to tamsulosin per UK guidelines. They're more commonly associated with other medications used in BPH management such as 5-alpha reductase inhibitors (e.g., finasteride).",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 69-year-old man is started on tamsulosin for benign prostatic hyperplasia. Which one of the following best describes the side-effects he may experience?",
        "correct_answer": "2",
        "question_notes": "The correct answer is <b>Dizziness + postural hypotension</b>. Tamsulosin, an alpha-1 adrenergic receptor antagonist, primarily acts to relax the smooth muscle in the prostate and bladder neck. This leads to improved urine flow and reduced symptoms of benign prostatic hyperplasia (BPH). However, it can also cause systemic vasodilation as a side effect, leading to dizziness and postural hypotension. The British National Formulary (BNF) lists these as common side effects of tamsulosin.<br /><br />The option <b>Urgency + insomnia</b> is incorrect. While urinary urgency can be a symptom of BPH itself, it's not typically a side effect of tamsulosin treatment. Insomnia is also not listed as a common side effect in the BNF.<br /><br /><b>Urinary retention + nausea</b> is another incorrect answer. Tamsulosin is used to alleviate urinary retention caused by BPH, so it wouldn't cause this problem as a side effect. Nausea isn't commonly associated with tamsulosin either.<br /><br />The choice <b>Urgency + erectile dysfunction</b> is also wrong. As previously mentioned, tamsulosin doesn't typically cause urinary urgency. Although some patients might experience erectile dysfunction while taking tamsulosin, this isn't one of its most common side effects according to the BNF.<br /><br />Finally, <b>Erectile dysfunction + reduced libido</b> isn't the best answer either. These aren't among the most frequently observed adverse reactions to tamsulosin per UK guidelines. They're more commonly associated with other medications used in BPH management such as 5-alpha reductase inhibitors (e.g., finasteride).",
        "answer_order": "2",
        "answer": "2",
        "title": "Benign prostatic hyperplasia",
        "body": "Benign prostatic hyperplasia (BPH) is a common condition seen in older men. <br /><br />Risk factors<br /><ul><li>age<ul><li>around 50% of 50-year-old men will have evidence of BPH and 30% will have symptoms</li><li>around 80% of 80-year-old men have evidence of BPH</li></ul></li><li>ethnicity: black > white > Asian</li></ul><br />BPH typically presents with lower urinary tract symptoms (LUTS), which may be categorised into:<br /><ul><li>voiding symptoms (obstructive): <ul><li>weak or intermittent urinary flow</li><li>straining</li><li>hesitancy</li><li>terminal dribbling</li><li>incomplete emptying</li></ul></li><li>storage symptoms (irritative)<ul><li>urgency</li><li>frequency</li><li>urgency incontinence</li><li>nocturia</li></ul></li><li>post-micturition<ul><li>dribbling</li></ul></li><li>complications<ul><li>urinary tract infection</li><li>retention</li><li>obstructive uropathy</li></ul></li></ul><br />Assessment<br /><ul><li>dipstick urine</li><li>U&Es: particularly if chronic retention is suspected</li><li>PSA: should be done if there are any obstructive symptoms, of if the patient is worried about prostate cancer</li><li> urinary frequency-volume chart<ul><li>should be done for at least 3 days</li></ul></li><li>International Prostate Symptom Score (IPSS)<ul><li> tool for classifying the severity of lower urinary tract symptoms (LUTS) and assessing the impact of LUTS on quality of life</li><li>Score 20-35: severely symptomatic</li><li>Score 8-19: moderately symptomatic</li><li>Score 0-7: mildly symptomatic</li></ul></li></ul><br />Management options<br /><ul><li>watchful waiting</li><li>alpha-1 antagonists  e.g. tamsulosin, alfuzosin<ul><li><span class=\"concept\" data-cid=\"2252\">decrease smooth muscle tone  of the prostate and bladder</span></li><li><span class=\"concept\" data-cid=\"11504\">considered first-line</span>: NICE recommend if moderate-to-severe voiding symptoms (IPSS \u2265 8)</li><li>improve symptoms in around 70% of men</li><li>adverse effects: dizziness, postural hypotension, dry mouth, depression</li></ul></li><li>5 alpha-reductase inhibitors  e.g. finasteride<ul><li>block the conversion of testosterone to dihydrotestosterone (DHT), which is known to induce BPH</li><li><span class=\"concept\" data-cid=\"11505\">indicated if the patient has a significantly enlarged prostate and is considered to be at high risk of progression</span></li><li>unlike alpha-1 antagonists causes a reduction in prostate volume and hence may slow disease progression. This however takes time and symptoms may not improve for <span class=\"concept\" data-cid=\"147\">6 months</span></li><li>may also decrease PSA concentrations by up to 50%</li><li>adverse effects: erectile dysfunction, reduced libido, ejaculation problems, gynaecomastia</li></ul></li><li>the use of <span class=\"concept\" data-cid=\"11506\">combination therapy</span> (alpha-1 antagonist +  5 alpha-reductase inhibitor) was supported by the Medical Therapy Of Prostatic Symptoms (MTOPS) trial and is also supported by NICE: '<i>If the man has bothersome moderate-to-severe voiding symptoms and prostatic enlargement</i>'</li><li>if there is a <span class=\"concept\" data-cid=\"11507\">mixture of storage symptoms and voiding symptoms</span> that persist after treatment with an alpha-blocker alone, then an antimuscarinic (anticholinergic) drug such as tolterodine or darifenacin may be tried</li><li>surgery<ul><li>transurethral resection of prostate (TURP)</li></ul></li></ul>",
        "notes_hash": "2f6a46757c1acf59f32eb15b1f99ae6f",
        "knowledge_graph_node_id_link": 1074,
        "concept": "",
        "concept_percentile": 0,
        "concept_colour": "",
        "number_attempts": "8263",
        "up_votes": "21",
        "down_votes": "5",
        "column_array": [
            0,
            "143",
            "6542",
            "224",
            "464",
            "890",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>NICE</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_735\" data-linkid=\"735\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_735\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">10</span><button type=\"button\" style=\"\" id=\"link_dislike_735\" data-linkid=\"735\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_735\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">6</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.nice.org.uk/guidance/CG97/chapter/1-Recommendations\">2010 The management of lower urinary tract symptoms in men</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/ifGWIIKHGrU\" data-description=\"Benign prostatic hyperplasia \" data-upvotes=\"1\" data-downvotes=\"2\" data-media=\"868\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/ifGWIIKHGrU/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/ifGWIIKHGrU\" data-description=\"Benign prostatic hyperplasia \" data-upvotes=\"1\" data-downvotes=\"2\" data-media=\"868\">Benign prostatic hyperplasia </a></td></tr><tr><td><span ><small>Osmosis - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1518\" data-mediaid=\"1518\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1518\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">1</span><button type=\"button\" style=\"\" id=\"media_dislike_1518\" data-mediaid=\"1518\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1518\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">2</span></td></tr></table>",
        "comment_count": 3,
        "concepts_for_notes": {
            "147": {
                "concept_text": "Finasteride treatment of BPH may take 6 months before results are seen",
                "concept_percentile": "79"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "1_B_943",
        "new_question_id": "3466",
        "question_type": "0",
        "category": "2",
        "concept_id_link": "345",
        "notes_id_link": "1_1586",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Advise paracetamol + emollients and reassure",
            "Admit to hospital",
            "Add hydrocortisone 1%",
            "Oral flucloxacillin",
            "Topical fusidic acid",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 2-year-old child with a history of atopic eczema is brought to the surgery. Her eczema is usually well controlled with emollients but her parents are concerned as the facial eczema has got significantly worse overnight. She now has painful clustered blisters on both cheeks, around her mouth on her neck. Her temperature is 37.9\u00baC. What is the most appropriate management?",
            "",
            ""
        ],
        "answers": [
            "2",
            "",
            ""
        ],
        "notes": [
            "The correct answer in this case is <b>Admit to hospital</b>. The child's symptoms, including the sudden worsening of eczema, painful clustered blisters on both cheeks, around her mouth and neck, and a temperature of 37.9\u00baC, suggest that she may have developed eczema herpeticum. Eczema herpeticum is a potentially serious complication caused by the herpes simplex virus (<i>Herpes simplex</i>) infecting areas of broken skin affected by atopic eczema. This condition requires urgent assessment and treatment with antiviral medication (e.g., acyclovir) in a hospital setting to prevent complications such as secondary bacterial infections or dissemination of the virus.<br /><br /><b>Advise paracetamol + emollients and reassure</b> would not be an appropriate management option in this case because it does not address the potential underlying viral infection causing the rapid deterioration in the child's condition.<br /><br />Adding <b>hydrocortisone 1%</b> could potentially exacerbate the situation if there is indeed an active herpes simplex infection. Topical corticosteroids can suppress local immune responses and worsen viral infections.<br /><br />Prescribing <b>oral flucloxacillin</b>, an antibiotic that targets bacterial infections, would not be effective against a viral infection like herpes simplex. Although it could help with any secondary bacterial infection that might be present, it would not address the primary cause of eczema herpeticum.<br /><br />Similarly, prescribing <b>topical fusidic acid</b>, another antibiotic used for treating bacterial skin infections, would not target the herpes simplex virus causing eczema herpeticum. It may help treat or prevent secondary bacterial infections but would not provide adequate management for this patient's presentation.<br /><br />In summary, given the child's sudden worsening of facial eczema along with painful blisters and fever, the most appropriate management is to <b>admit to hospital</b> for assessment and treatment of potential eczema herpeticum.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 2-year-old child with a history of atopic eczema is brought to the surgery. Her eczema is usually well controlled with emollients but her parents are concerned as the facial eczema has got significantly worse overnight. She now has painful clustered blisters on both cheeks, around her mouth on her neck. Her temperature is 37.9\u00baC. What is the most appropriate management?",
        "correct_answer": "2",
        "question_notes": "The correct answer in this case is <b>Admit to hospital</b>. The child's symptoms, including the sudden worsening of eczema, painful clustered blisters on both cheeks, around her mouth and neck, and a temperature of 37.9\u00baC, suggest that she may have developed eczema herpeticum. Eczema herpeticum is a potentially serious complication caused by the herpes simplex virus (<i>Herpes simplex</i>) infecting areas of broken skin affected by atopic eczema. This condition requires urgent assessment and treatment with antiviral medication (e.g., acyclovir) in a hospital setting to prevent complications such as secondary bacterial infections or dissemination of the virus.<br /><br /><b>Advise paracetamol + emollients and reassure</b> would not be an appropriate management option in this case because it does not address the potential underlying viral infection causing the rapid deterioration in the child's condition.<br /><br />Adding <b>hydrocortisone 1%</b> could potentially exacerbate the situation if there is indeed an active herpes simplex infection. Topical corticosteroids can suppress local immune responses and worsen viral infections.<br /><br />Prescribing <b>oral flucloxacillin</b>, an antibiotic that targets bacterial infections, would not be effective against a viral infection like herpes simplex. Although it could help with any secondary bacterial infection that might be present, it would not address the primary cause of eczema herpeticum.<br /><br />Similarly, prescribing <b>topical fusidic acid</b>, another antibiotic used for treating bacterial skin infections, would not target the herpes simplex virus causing eczema herpeticum. It may help treat or prevent secondary bacterial infections but would not provide adequate management for this patient's presentation.<br /><br />In summary, given the child's sudden worsening of facial eczema along with painful blisters and fever, the most appropriate management is to <b>admit to hospital</b> for assessment and treatment of potential eczema herpeticum.",
        "answer_order": "2",
        "answer": "2",
        "title": "Eczema herpeticum",
        "body": "Eczema herpeticum describes a severe primary infection of the skin by <span class=\"concept\" data-cid=\"10256\">herpes simplex virus</span> 1 or 2. <br /><br />It is more commonly seen in children with atopic eczema and often presents as a <span class=\"concept\" data-cid=\"10260\">rapidly progressing painful rash</span>. <br /><br /><div class=\"container\"><div class=\"row\"><div class=\"col-md-3\"><a href=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd454b.jpg\" data-fancybox=\"gallery\" data-caption=\"This image shows a child with widespread monomorphic vesiculopustular and erosive lesions on the cheeks, perioral area, and chin, many with haemorrhagic crusting. The lesions are punched-out, confluent in areas, and set on a background of erythema, consistent with eczema herpeticum\u2014a disseminated herpes simplex virus (HSV) infection typically superimposed on atopic dermatitis. The distribution around the mouth and lower face is characteristic.\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd454.jpg\" alt=\"\" /></a></div><div class=\"col-md-3\"><a href=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd050b.jpg\" data-fancybox=\"gallery\" data-caption=\"Eczema herpeticum\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd050.jpg\" alt=\"\" /></a></div></div></div><br />On examination, <span class=\"concept\" data-cid=\"10261\">monomorphic punched-out erosions (circular, depressed, ulcerated lesions) usually 1-3 mm in diameter</span> are typically seen.<br /><br />As it is potentially life-threatening children should be <span class=\"concept\" data-cid=\"10262\">admitted</span> for <span class=\"concept\" data-cid=\"345\">IV aciclovir</span>.",
        "notes_hash": "24ffb2e3dec3f3543f328cfdfa457c0f",
        "knowledge_graph_node_id_link": 11038,
        "concept": "Eczema herpeticum is a serious condition that requires IV antivirals",
        "concept_percentile": "88",
        "concept_colour": "rgb(61,255,0)",
        "number_attempts": "6337",
        "up_votes": "29",
        "down_votes": "8",
        "column_array": [
            0,
            "215",
            "4496",
            "394",
            "502",
            "730",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>DermNet NZ</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_463\" data-linkid=\"463\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_463\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">43</span><button type=\"button\" style=\"\" id=\"link_dislike_463\" data-linkid=\"463\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_463\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">18</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.dermnetnz.org/topics/eczema-herpeticum/\">Eczema herpeticum</a></td></tr></table>",
        "media": "",
        "comment_count": 1,
        "concepts_for_notes": {
            "345": {
                "concept_text": "Eczema herpeticum is a serious condition that requires IV antivirals",
                "concept_percentile": "88"
            },
            "10256": {
                "concept_text": "Eczema herpeticum is a primary infection of the skin caused by herpes simplex virus (HSV) and uncommonly coxsackievirus",
                "concept_percentile": "82"
            },
            "10261": {
                "concept_text": "Eczema herperticum rash can be described as monomorphic punched-out erosions (circular, depressed, ulcerated lesions) usually 1-3 mm in diameter",
                "concept_percentile": "100"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "4579_B_140",
        "new_question_id": "16891",
        "question_type": "0",
        "category": "9",
        "concept_id_link": "2683",
        "notes_id_link": "1_2681",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Blockage of presynaptic alpha 1 adrenoreceptors",
            "Selective noradrenaline reuptake inhibitors",
            "Selective serotonin reuptake inhibitor",
            "Serotonin and noradrenaline reuptake inhibitor",
            "Blockage of presynaptic alpha 2 adrenoreceptors",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "Venlafaxine is an antidepressant used in the treatment of major depression, anxiety and panic disorder. <br /><br />Which description is the most accurate for the mechanism of this drug?",
            "",
            ""
        ],
        "answers": [
            "4",
            "0",
            "0"
        ],
        "notes": [
            "Venlafaxine is a serotonin and noradrenaline reuptake inhibitor (SNRI). This increases the synaptic concentrations of these neurotransmitters giving its effects. Alpha 2 receptors, noradrenaline and serotonin are all utilised to treat depression.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "Venlafaxine is an antidepressant used in the treatment of major depression, anxiety and panic disorder. <br /><br />Which description is the most accurate for the mechanism of this drug?",
        "correct_answer": "4",
        "question_notes": "Venlafaxine is a serotonin and noradrenaline reuptake inhibitor (SNRI). This increases the synaptic concentrations of these neurotransmitters giving its effects. Alpha 2 receptors, noradrenaline and serotonin are all utilised to treat depression.",
        "answer_order": "4",
        "answer": "4",
        "title": "Serotonin and noradrenaline reuptake inhibitors",
        "body": "Serotonin and noradrenaline reuptake inhibitor (SNRI's) are a class of relatively new antidepressants.  Inhibiting the reuptake increases the concentrations of serotonin and noradrenaline in the synaptic cleft leading to the effects. Examples include <span class=\"concept\" data-cid=\"2683\">venlafaxine</span> and <span class=\"concept\" data-cid=\"2682\">duloxetine</span>. They are used to treat major depressive disorders, generalised anxiety disorder, social anxiety disorder and panic disorder and menopausal symptoms.",
        "notes_hash": "256b1e7dec817b81f728e1986bdb942f",
        "knowledge_graph_node_id_link": 10860,
        "concept": "Venlafaxine mechanism of action = serotonin and noradrenaline reuptake inhibitor",
        "concept_percentile": "58",
        "concept_colour": "rgb(214,255,0)",
        "number_attempts": "5494",
        "up_votes": "29",
        "down_votes": "17",
        "column_array": [
            0,
            "87",
            "1687",
            "587",
            "3002",
            "131",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/T25jvLC6X0w\" data-description=\"Antidepressants\" data-upvotes=\"3\" data-downvotes=\"0\" data-media=\"631\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/T25jvLC6X0w/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/T25jvLC6X0w\" data-description=\"Antidepressants\" data-upvotes=\"3\" data-downvotes=\"0\" data-media=\"631\">Antidepressants</a></td></tr><tr><td><span ><small>Speed Pharmacology - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1083\" data-mediaid=\"1083\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1083\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">3</span><button type=\"button\" style=\"\" id=\"media_dislike_1083\" data-mediaid=\"1083\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1083\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr></table>",
        "comment_count": 1,
        "concepts_for_notes": {
            "2683": {
                "concept_text": "Venlafaxine mechanism of action = serotonin and noradrenaline reuptake inhibitor",
                "concept_percentile": "58"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "23539_B_409",
        "new_question_id": "41464",
        "question_type": "0",
        "category": "11",
        "concept_id_link": "11843",
        "notes_id_link": "1_1708",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "IM carboprost",
            "IV carboprost",
            "IV oxytocin",
            "IV tocolytics",
            "Intrauterine balloon tamponade",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 25-year-old woman undergoes a vaginal delivery at 39 weeks gestation, followed by a physiological third stage of labour. Shortly after, she loses 600ml of blood. Help is called for, and an ABCDE assessment is made. IV access is obtained, and she is given warmed IV crystalloid fluids. She is catheterised, and the uterus has been compressed to stimulate contractions however, she continues to lose blood.<br /><br />The patient's only medical history includes asthma, and she does not have any known coagulopathy.<br /><br />What is the most appropriate next step in her management?",
            "",
            ""
        ],
        "answers": [
            "3",
            "0",
            "0"
        ],
        "notes": [
            "This patient has lost >500 ml of blood shortly after delivery, meaning she is in postpartum haemorrhage (PPH), the most likely cause of which is uterine atony. <br /><br /><b>IV oxytocin</b> is correct. The first steps in management are an ABCDE approach, gaining IV access, giving warm crystalloid, and palpating the uterine fundus ('rubbing up the uterus') to stimulate uterine contraction and catheterisation to prevent bladder distention. These measures have not been successful. Therefore, the next step is to initiate medical therapy, which involves IV oxytocin.<br /><br /><b>IM carboprost</b> is incorrect. Although this is another medical therapy that may be used, it requires senior approval before being given and can exacerbate bronchoconstriction in patients with asthma and, therefore, should be avoided.<br /><br /><b>IV carboprost</b> is incorrect. As mentioned above, this is avoided in patients with asthma and is not given intravenously, as this is associated with an increased risk of bronchospasm, hypertension, and fever. It also requires senior approval before administration and this can delay treatment.<br /><br /><b>IV tocolytics</b> is incorrect as these suppress uterine contractions, which would worsen the problem in this case. This case of PPH is most likely to be due to uterine atony, therefore, agents are given to stimulate uterine contraction. Giving tocolytics in this case would do the opposite and worsen the patient's PPH.<br /><br /><b>Intrauterine balloon tamponade</b> is incorrect. This is the first-line 'surgical' step in the management of PPH. Given that no medical treatment has been tried yet in this patient jumping to this step may unnecessary and inappropriate.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 25-year-old woman undergoes a vaginal delivery at 39 weeks gestation, followed by a physiological third stage of labour. Shortly after, she loses 600ml of blood. Help is called for, and an ABCDE assessment is made. IV access is obtained, and she is given warmed IV crystalloid fluids. She is catheterised, and the uterus has been compressed to stimulate contractions however, she continues to lose blood.<br /><br />The patient's only medical history includes asthma, and she does not have any known coagulopathy.<br /><br />What is the most appropriate next step in her management?",
        "correct_answer": "3",
        "question_notes": "This patient has lost >500 ml of blood shortly after delivery, meaning she is in postpartum haemorrhage (PPH), the most likely cause of which is uterine atony. <br /><br /><b>IV oxytocin</b> is correct. The first steps in management are an ABCDE approach, gaining IV access, giving warm crystalloid, and palpating the uterine fundus ('rubbing up the uterus') to stimulate uterine contraction and catheterisation to prevent bladder distention. These measures have not been successful. Therefore, the next step is to initiate medical therapy, which involves IV oxytocin.<br /><br /><b>IM carboprost</b> is incorrect. Although this is another medical therapy that may be used, it requires senior approval before being given and can exacerbate bronchoconstriction in patients with asthma and, therefore, should be avoided.<br /><br /><b>IV carboprost</b> is incorrect. As mentioned above, this is avoided in patients with asthma and is not given intravenously, as this is associated with an increased risk of bronchospasm, hypertension, and fever. It also requires senior approval before administration and this can delay treatment.<br /><br /><b>IV tocolytics</b> is incorrect as these suppress uterine contractions, which would worsen the problem in this case. This case of PPH is most likely to be due to uterine atony, therefore, agents are given to stimulate uterine contraction. Giving tocolytics in this case would do the opposite and worsen the patient's PPH.<br /><br /><b>Intrauterine balloon tamponade</b> is incorrect. This is the first-line 'surgical' step in the management of PPH. Given that no medical treatment has been tried yet in this patient jumping to this step may unnecessary and inappropriate.",
        "answer_order": "3",
        "answer": "3",
        "title": "Postpartum haemorrhage",
        "body": "Postpartum haemorrhage (PPH) is defined as blood loss of > <span class=\"concept\" data-cid=\"5407\">500 ml</span> after a vaginal delivery and may be primary or secondary.<br /><br /><h5 class='notes-heading'>Primary postpartum haemorrhage</h5><br />Primary PPH occurs within 24 hours. It affects around 5-7% of deliveries. <br /><br />The causes of PPH are said to be the 4 Ts:<br /><ul><li><b>T</b>one <span class=\"concept\" data-cid=\"1224\">(uterine atony): the vast majority of cases</span></li><li><b>T</b>rauma (e.g. perineal tear)</li><li><b>T</b>issue (retained placenta)</li><li><b>T</b>hrombin (e.g. clotting/bleeding disorder)</li></ul><br />Risk factors for primary PPH include*:<br /><ul><li>previous PPH</li><li>prolonged labour</li><li>pre-eclampsia</li><li>increased maternal age</li><li>polyhydramnios</li><li>emergency Caesarean section</li><li>placenta praevia, placenta accreta</li><li>macrosomia</li><li>the effect of parity on the risk of PPH is complicated. It was previously thought multiparity was a risk factor but more modern studies suggest nulliparity is actually a risk factor</li></ul><br />Management<br /><ul><li>PPH is a life-threatening emergency - senior members of staff should be involved immediately</li><li>ABC approach<ul><li>two peripheral cannulae, 14 gauge</li><li>lie the woman flat</li><li>bloods including group and save</li><li>commence warmed crystalloid infusion</li></ul></li><li><span class=\"concept\" data-cid=\"3147\">mechanical</span><ul><li>palpate the uterine fundus and rub it to stimulate contractions ('rubbing up the fundus')</li><li>catheterisation to prevent bladder distension and monitor urine output</li></ul></li><li><span class=\"concept\" data-cid=\"11843\">medical</span><ul><li>IV oxytocin: slow IV injection followed by an IV infusion</li><li>ergometrine slow IV or IM (unless there is a history of hypertension)</li><li>carboprost IM (unless there is a history of asthma)</li><li>misoprostol sublingual </li><li><span class=\"concept\" data-cid=\"12418\">early use of tranexamic acid has been shown to reduce the risk of  death in PPH</span></li></ul></li><li> surgical: if medical options fail to control the bleeding then surgical options will need to be urgently considered<ul><li>the RCOG state that the <span class=\"concept\" data-cid=\"11844\">intrauterine balloon tamponade</span> is an appropriate first-line 'surgical' intervention for most women where uterine atony is the only or main cause of haemorrhage</li><li>other options include: B-Lynch suture, ligation of the uterine arteries or internal iliac arteries</li><li>if severe, uncontrolled haemorrhage then a hysterectomy is sometimes performed as a life-saving procedure</li></ul></li></ul><br /><h5 class='notes-heading'>Secondary postpartum haemorrhage</h5><br />Secondary PPH occurs between 24 hours -  12 weeks. It is typically due to retained placental tissue or endometritis.",
        "notes_hash": "cae7a02d7b31156f46902ccc9d103a28",
        "knowledge_graph_node_id_link": 11145,
        "concept": "Medical treatments for postpartum haemorrhage secondary to uterine atony include oxytocin, ergometrine, carboprost and misoprostol <br />",
        "concept_percentile": "76",
        "concept_colour": "rgb(122,255,0)",
        "number_attempts": "7030",
        "up_votes": "37",
        "down_votes": "7",
        "column_array": [
            0,
            "292",
            "372",
            "5033",
            "405",
            "928",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>RCOG</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_91\" data-linkid=\"91\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_91\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">4</span><button type=\"button\" style=\"\" id=\"link_dislike_91\" data-linkid=\"91\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_91\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">6</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://obgyn.onlinelibrary.wiley.com/doi/full/10.1111/1471-0528.14178\">2016 Post-partum haemorrhage guidelines</a></td></tr></table><br><br><table style='width:100%'><tr><td>Cochrane </td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1283\" data-linkid=\"1283\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_1283\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">8</span><button type=\"button\" style=\"\" id=\"link_dislike_1283\" data-linkid=\"1283\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_1283\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">7</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.cochrane.org/CD008020/PREG_cord-traction-deliver-afterbirth\">Cord traction to deliver the afterbirth</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/SEQPKTceWp4\" data-description=\"Postpartum hemorrhage\" data-upvotes=\"5\" data-downvotes=\"0\" data-media=\"218\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/css/images/osmosis.png\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/SEQPKTceWp4\" data-description=\"Postpartum hemorrhage\" data-upvotes=\"5\" data-downvotes=\"0\" data-media=\"218\">Postpartum hemorrhage</a></td></tr><tr><td><span ><small>Osmosis - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_362\" data-mediaid=\"362\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_362\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">5</span><button type=\"button\" style=\"\" id=\"media_dislike_362\" data-mediaid=\"362\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_362\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/fSX9EYwkN7U\" data-description=\"Sheehan's Syndrome\" data-upvotes=\"6\" data-downvotes=\"2\" data-media=\"367\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/fSX9EYwkN7U/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/fSX9EYwkN7U\" data-description=\"Sheehan's Syndrome\" data-upvotes=\"6\" data-downvotes=\"2\" data-media=\"367\">Sheehan's Syndrome</a></td></tr><tr><td><span ><small>Osmosis - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_765\" data-mediaid=\"765\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_765\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">6</span><button type=\"button\" style=\"\" id=\"media_dislike_765\" data-mediaid=\"765\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_765\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">2</span></td></tr></table>",
        "comment_count": 3,
        "concepts_for_notes": {
            "3147": {
                "concept_text": "Following an ABC approach, initial steps to manage a postpartum haemorrhage include palpating the uterine fundus and catheterising the patient",
                "concept_percentile": "95"
            },
            "11843": {
                "concept_text": "Medical treatments for postpartum haemorrhage secondary to uterine atony include oxytocin, ergometrine, carboprost and misoprostol \n",
                "concept_percentile": "76"
            }
        },
        "optimisation_reason": ""
    }
]